FEATURED COMPANIES
- CiceroDx
- CooperSurgical, Inc.
- FertiPro N.V
- Hamilton Thorne, Inc.
- iGLS
- Kitazato Corporation
This report on the in vitro fertilization test market studies the past as well as the current growth trends and opportunities to gain valuable insights of the indicators of the market over the forecast period from 2021 to 2031. The report provides the overall revenue of the global in vitro fertilization test market for the period of 2017-2031, considering 2020 as the base year and 2031 as the forecast year. The report also provides the compound annual growth rate (CAGR) of the global in vitro fertilization test market for the forecast period of 2021-2031.
The report has been prepared after an extensive research. Primary research involved bulk of the research efforts, wherein analysts carried out interviews with industry leaders and opinion makers. Secondary research involved referring to key players’ product literature, annual reports, press releases, and relevant documents to understand the global in vitro fertilization test market.
Secondary research also included Internet sources, statistical data from government agencies, websites, and trade associations. Analysts employed a combination of top-down and bottom-up approaches to study various phenomena in the global in vitro fertilization test market.
The report includes an elaborate executive summary, along with a snapshot of the growth behavior of various segments in the scope of the study. Moreover, the report sheds light on the changing competitive dynamics in the in vitro fertilization test market. These indices serve as valuable tools for existing market players as well as for entities interested in participating in the in vitro fertilization test market.
The report also delves into the competitive landscape of the global in vitro fertilization test market. Key players operating in the global in vitro fertilization test market have been identified and each one of these has been profiled for distinguishing business attributes. Company overview, financial standings, recent developments, and SWOT are some of the attributes of players in the in vitro fertilization test market profiled in this report.
Key Questions Answered in the Report
The comprehensive report on the global in vitro fertilization test market begins with an overview of the market, followed by the scope and objectives of this study. Following this, the report provides detailed explanation of the objectives behind this study and healthcare compliances laid down by accredited agencies in the purview of line of procedure for in vitro fertilization test.
For reading comprehensibility, the report is compiled in a chapter-wise layout, with each section further divided into smaller ones. The entire report comprises an exhaustive collection of graphs and tables that are appropriately interspersed in the entire compilation. Pictorial representation of actual and projected values of key segments is visually appealing to readers. This also allows comparison of the market shares of key segments in the past and at the end of the forecast period.
The report analyzes the global in vitro fertilization test market in terms of test type, end user, and region. Key segments under each criteria are studied at length, and the market share for each of these at the end of 2031 has been provided. Such valuable insights enable market stakeholders in making informed business decisions for investment in the global in vitro fertilization test market.
The report has been prepared after an extensive research. Primary research involved bulk of the research efforts, wherein analysts carried out interviews with industry leaders and opinion makers. Secondary research involved referring to key players’ product literature, annual reports, press releases, and relevant documents to understand the global in vitro fertilization test market.
Secondary research also included Internet sources, statistical data from government agencies, websites, and trade associations. Analysts employed a combination of top-down and bottom-up approaches to study various phenomena in the global in vitro fertilization test market.
The report includes an elaborate executive summary, along with a snapshot of the growth behavior of various segments in the scope of the study. Moreover, the report sheds light on the changing competitive dynamics in the in vitro fertilization test market. These indices serve as valuable tools for existing market players as well as for entities interested in participating in the in vitro fertilization test market.
The report also delves into the competitive landscape of the global in vitro fertilization test market. Key players operating in the global in vitro fertilization test market have been identified and each one of these has been profiled for distinguishing business attributes. Company overview, financial standings, recent developments, and SWOT are some of the attributes of players in the in vitro fertilization test market profiled in this report.
Key Questions Answered in the Report
- How does the development of in vitro fertilization tests provide scope of growth in the global in vitro fertilization test market?
- How alliances and partnerships among players are widening the scope of new line of technologies for in vitro fertilization test?
- What are the revenue share projections of key segments under various criteria in the in vitro fertilization test market during the forecast period?
- Which segment is likely to register highest revenue until the end of the forecast period in 2031?
- How is the evolving healthcare system in developing countries in Asia Pacific making an impact on the overall in vitro fertilization test market?
The comprehensive report on the global in vitro fertilization test market begins with an overview of the market, followed by the scope and objectives of this study. Following this, the report provides detailed explanation of the objectives behind this study and healthcare compliances laid down by accredited agencies in the purview of line of procedure for in vitro fertilization test.
For reading comprehensibility, the report is compiled in a chapter-wise layout, with each section further divided into smaller ones. The entire report comprises an exhaustive collection of graphs and tables that are appropriately interspersed in the entire compilation. Pictorial representation of actual and projected values of key segments is visually appealing to readers. This also allows comparison of the market shares of key segments in the past and at the end of the forecast period.
The report analyzes the global in vitro fertilization test market in terms of test type, end user, and region. Key segments under each criteria are studied at length, and the market share for each of these at the end of 2031 has been provided. Such valuable insights enable market stakeholders in making informed business decisions for investment in the global in vitro fertilization test market.
Note: Product cover images may vary from those shown
FEATURED COMPANIES
- CiceroDx
- CooperSurgical, Inc.
- FertiPro N.V
- Hamilton Thorne, Inc.
- iGLS
- Kitazato Corporation
1. Preface
1.1. Market Definition and Scope
1.2. Market Segmentation
1.3. Key Research Objectives
1.4. Research Highlights
2. Assumptions and Research Methodology
3. Executive Summary: Global In Vitro Fertilization Test Market
4. Market Overview
4.1. Introduction
4.1.1. Market Introduction
4.1.2. Industry Evolution / Developments
4.2. Overview
4.3. Market Dynamics
4.3.1. Drivers
4.3.2. Restraints
4.3.3. Opportunities
4.4. Global In Vitro Fertilization Test Market Analysis and Forecast, 2017-2031
4.4.1. Market Revenue Projections (US$ Mn)
5. Key Insights
5.1. Key Mergers & Acquisitions
5.2. COVID-19 Pandemics Impact on Industry (Value Chain and Short / Mid /Long Term Impact)
5.3. Regulatory Scenario by Region/globally
5.4. Top 3 players operating in the market space
5.5. Key product/brand Analysis
6. Global In Vitro Fertilization Test Market Analysis and Forecast, by Test Type
6.1. Introduction & Definition
6.2. Key Findings / Developments
6.3. Market Value Forecast, by Test Type, 2017-2031
6.3.1. Sperm Aneuploidy Test
6.3.2. Genetic Compatibility Test
6.3.3. Preimplantation Genetic Testing
6.3.4. Endometrial Receptivity Analysis
6.3.5. Noninvasive Prenatal Testing
6.3.6. Others
6.4. Market Attractiveness Analysis, by Test Type
7. Global In Vitro Fertilization Test Market Analysis and Forecast, by End-user
7.1. Introduction & Definition
7.2. Key Findings / Developments
7.3. Market Value Forecast, by End-user, 2017-2031
7.3.1. Fertility Clinics
7.3.2. Hospitals
7.3.3. Others
7.4. Market Attractiveness Analysis, by End-user
8. Global In Vitro Fertilization Test Market Analysis and Forecast, by Region
8.1. Key Findings
8.2. Market Value Forecast by Region
8.2.1. North America
8.2.2. Europe
8.2.3. Asia Pacific
8.2.4. Latin America
8.2.5. Middle East & Africa
8.3. Market Attractiveness Analysis, by Country/Region
9. North America In Vitro Fertilization Test Market Analysis and Forecast
9.1. Introduction
9.1.1. Key Findings
9.2. Market Value Forecast, by Test Type, 2017-2031
9.2.1. Sperm Aneuploidy Test
9.2.2. Genetic Compatibility Test
9.2.3. Preimplantation Genetic Testing
9.2.4. Endometrial Receptivity Analysis
9.2.5. Noninvasive Prenatal Testing
9.2.6. Others
9.3. Market Value Forecast, by End-user, 2017-2031
9.3.1. Fertility Clinics
9.3.2. Hospitals
9.3.3. Others
9.4. Market Value Forecast, by Country, 2017-2031
9.4.1. U.S.
9.4.2. Canada
9.5. Market Attractiveness Analysis
9.5.1. By Test Type
9.5.2. By End-user
9.5.3. By Country
10. Europe In Vitro Fertilization Test Market Analysis and Forecast
10.1. Introduction
10.1.1. Key Findings
10.2. Market Value Forecast, by Test Type, 2017-2031
10.2.1. Sperm Aneuploidy Test
10.2.2. Genetic Compatibility Test
10.2.3. Preimplantation Genetic Testing
10.2.4. Endometrial Receptivity Analysis
10.2.5. Noninvasive Prenatal Testing
10.2.6. Others
10.3. Market Value Forecast, by End-user, 2017-2031
10.3.1. Fertility Clinics
10.3.2. Hospitals
10.3.3. Others
10.4. Market Value Forecast, by Country/Sub-region, 2017-2031
10.4.1. Germany
10.4.2. U.K.
10.4.3. France
10.4.4. Spain
10.4.5. Italy
10.4.6. Rest of Europe
10.5. Market Attractiveness Analysis
10.5.1. By Test Type
10.5.2. By End-user
10.5.3. By Country/Sub-region
11. Asia Pacific In Vitro Fertilization Test Market Analysis and Forecast
11.1. Introduction
11.1.1. Key Findings
11.2. Market Value Forecast, by Test Type, 2017-2031
11.2.1. Sperm Aneuploidy Test
11.2.2. Genetic Compatibility Test
11.2.3. Preimplantation Genetic Testing
11.2.4. Endometrial Receptivity Analysis
11.2.5. Noninvasive Prenatal Testing
11.2.6. Others
11.3. Market Value Forecast, by End-user, 2017-2031
11.3.1. Fertility Clinics
11.3.2. Hospitals
11.3.3. Others
11.4. Market Value Forecast, by Country/Sub-region, 2017-2031
11.4.1. China
11.4.2. Japan
11.4.3. India
11.4.4. Australia & New Zealand
11.4.5. Rest of Asia Pacific
11.5. Market Attractiveness Analysis
11.5.1. By Test Type
11.5.2. By End-user
11.5.3. By Country/Sub-region
12. Latin America In Vitro Fertilization Test Market Analysis and Forecast
12.1. Introduction
12.1.1. Key Findings
12.2. Market Value Forecast, by Test Type, 2017-2031
12.2.1. Sperm Aneuploidy Test
12.2.2. Genetic Compatibility Test
12.2.3. Preimplantation Genetic Testing
12.2.4. Endometrial Receptivity Analysis
12.2.5. Noninvasive Prenatal Testing
12.2.6. Others
12.3. Market Value Forecast, by End-user, 2017-2031
12.3.1. Fertility Clinics
12.3.2. Hospitals
12.3.3. Others
12.4. Market Value Forecast, by Country/Sub-region, 2017-2031
12.4.1. Brazil
12.4.2. Mexico
12.4.3. Rest of Latin America
12.5. Market Attractiveness Analysis
12.5.1. By Test Type
12.5.2. By End-user
12.5.3. By Country/Sub-region
13. Middle East & Africa In Vitro Fertilization Test Market Analysis and Forecast
13.1. Introduction
13.1.1. Key Findings
13.2. Market Value Forecast, by Test Type, 2017-2031
13.2.1. Sperm Aneuploidy Test
13.2.2. Genetic Compatibility Test
13.2.3. Preimplantation Genetic Testing
13.2.4. Endometrial Receptivity Analysis
13.2.5. Noninvasive Prenatal Testing
13.2.6. Others
13.3. Market Value Forecast, by End-user, 2017-2031
13.3.1. Fertility Clinics
13.3.2. Hospitals
13.3.3. Others
13.4. Market Value Forecast, by Country/Sub-region, 2017-2031
13.4.1. GCC Countries
13.4.2. South Africa
13.4.3. Rest of Middle East & Africa
13.5. Market Attractiveness Analysis
13.5.1. By Test Type
13.5.2. By End-user
13.5.3. By Country/Sub-region
14. Competition Landscape
14.1. Market Player - Competition Matrix (by Tier and Size of companies)
14.2. Market Share Analysis, by Company, 2020
14.3. Company Profiles
14.3.1. CooperSurgical, Inc.
14.3.1.1. Company Overview (HQ, Business Segments, Employee Strength)
14.3.1.2. Growth Strategies
14.3.1.3. SWOT Analysis
14.3.2. Esco Micro Pte Ltd.
14.3.2.1. Company Overview (HQ, Business Segments, Employee Strength)
14.3.2.2. Growth Strategies
14.3.2.3. SWOT Analysis
14.3.3. FUJIFILM Irvine Scientific
14.3.3.1. Company Overview (HQ, Business Segments, Employee Strength)
14.3.3.2. Growth Strategies
14.3.3.3. SWOT Analysis
14.3.4. Hamilton Thorne, Inc.
14.3.4.1. Company Overview (HQ, Business Segments, Employee Strength)
14.3.4.2. Growth Strategies
14.3.4.3. SWOT Analysis
14.3.5. Vitrolife AB
14.3.5.1. Company Overview (HQ, Business Segments, Employee Strength)
14.3.5.2. Growth Strategies
14.3.5.3. SWOT Analysis
14.3.6. IVFtech ApS
14.3.6.1. Company Overview (HQ, Business Segments, Employee Strength)
14.3.6.2. Growth Strategies
14.3.6.3. SWOT Analysis
14.3.7. Nidacon International AB
14.3.7.1. Company Overview (HQ, Business Segments, Employee Strength)
14.3.7.2. Growth Strategies
14.3.7.3. SWOT Analysis
14.3.8. Igenomix
14.3.8.1. Company Overview (HQ, Business Segments, Employee Strength)
14.3.8.2. Growth Strategies
14.3.8.3. SWOT Analysis
14.3.9. Thermo Fisher Scientific
14.3.9.1. Company Overview (HQ, Business Segments, Employee Strength)
14.3.9.2. Growth Strategies
14.3.9.3. SWOT Analysis
14.3.10. Cook
14.3.10.1. Company Overview (HQ, Business Segments, Employee Strength)
14.3.10.2. Growth Strategies
14.3.10.3. SWOT Analysis
14.3.11. Genea Biomedx
14.3.11.1. Company Overview (HQ, Business Segments, Employee Strength)
14.3.11.2. Growth Strategies
14.3.11.3. SWOT Analysis
14.3.12. FertiPro N.V
14.3.12.1. Company Overview (HQ, Business Segments, Employee Strength)
14.3.12.2. Growth Strategies
14.3.12.3. SWOT Analysis
14.3.13. Kitazato Corporation
14.3.13.1. Company Overview (HQ, Business Segments, Employee Strength)
14.3.13.2. Growth Strategies
14.3.13.3. SWOT Analysis
14.3.14. PerkinElmer, Inc.
14.3.14.1. Company Overview (HQ, Business Segments, Employee Strength)
14.3.14.2. Growth Strategies
14.3.14.3. SWOT Analysis
14.3.15. Natera
14.3.15.1. Company Overview (HQ, Business Segments, Employee Strength)
14.3.15.2. Growth Strategies
14.3.15.3. SWOT Analysis
14.3.16. Takara Bio, Inc.
14.3.16.1. Company Overview (HQ, Business Segments, Employee Strength)
14.3.16.2. Growth Strategies
14.3.16.3. SWOT Analysis
14.3.17. iGLS
14.3.17.1. Company Overview (HQ, Business Segments, Employee Strength)
14.3.17.2. Growth Strategies
14.3.17.3. SWOT Analysis
14.3.18. CiceroDx
14.3.18.1. Company Overview (HQ, Business Segments, Employee Strength)
14.3.18.2. Growth Strategies
14.3.18.3. SWOT Analysis
List of Tables
Table 01: Global In Vitro Fertilization Test Market Value (US$ Mn) Forecast, by Test Type, 2017-2031
Table 02: Global In Vitro Fertilization Test Market Value (US$ Mn) Forecast, by End-user, 2017-2031
Table 03: Global In Vitro Fertilization Test Market Value (US$ Mn) Forecast, by Region, 2017-2031
Table 04: North America In Vitro Fertilization Test Market Value (US$ Mn) Forecast, by Country, 2017-2031
Table 05: North America In Vitro Fertilization Test Market Value (US$ Mn) Forecast, by Test Type, 2017-2031
Table 06: North America In Vitro Fertilization Test Market Value (US$ Mn) Forecast, by End-user, 2017-2031
Table 07: Europe In Vitro Fertilization Test Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017-2031
Table 08: Europe In Vitro Fertilization Test Market Value (US$ Mn) Forecast, by Test Type, 2017-2031
Table 09: Europe In Vitro Fertilization Test Market Value (US$ Mn) Forecast, by End-user, 2017-2031
Table 10: Asia Pacific In Vitro Fertilization Test Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017-2031
Table 11: Asia Pacific In Vitro Fertilization Test Market Value (US$ Mn) Forecast, by Test Type, 2017-2031
Table 12: Asia Pacific In Vitro Fertilization Test Market Value (US$ Mn) Forecast, by End-user, 2017-2031
Table 13: Latin America In Vitro Fertilization Test Market Value (US$ Mn) Forecast, by Country/Sub-Region, 2017-2031
Table 14: Latin America In Vitro Fertilization Test Market Value (US$ Mn) Forecast, by Test Type, 2017-2031
Table 15: Latin America In Vitro Fertilization Test Market Value (US$ Mn) Forecast, by End-user, 2017-2031
Table 16: Middle East & Africa In Vitro Fertilization Test Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017-2031
Table 17: Middle East & Africa In Vitro Fertilization Test Market Value (US$ Mn) Forecast, by Test Type, 2017-2031
Table 18: Middle East & Africa In Vitro Fertilization Test Market Value (US$ Mn) Forecast, by End-user, 2017-2031
List of Figures
Figure 01: Global In-vitro Fertilization Test Market Value (US$ Mn) Forecast, 2017-2031
Figure 02: Global In-vitro Fertilization Test Market Value Share, by Test Type, 2020
Figure 03: Global In-vitro Fertilization Test Market Value Share, by End-user, 2020
Figure 04: Global In-vitro Fertilization Test Market Value Share, by Region, 2020
Figure 05: Global In Vitro Fertilization Test Market Value Share Analysis, by Test Type, 2020 and 2031
Figure 06: Global In Vitro Fertilization Test Market Attractiveness Analysis, by Test Type, 2021-2031
Figure 07: Global In Vitro Fertilization Test Market Value (US$ Mn), by Sperm Aneuploidy Test, 2017-2031
Figure 08: Global In Vitro Fertilization Test Market Value (US$ Mn), by Genetic Compatibility Test, 2017-2031
Figure 09: Global In Vitro Fertilization Test Market Value (US$ Mn), by Preimplantation Genetic Testing, 2017-2031
Figure 10: Global In Vitro Fertilization Test Market Value (US$ Mn), by Endometrial Receptivity Analysis, 2017-2031
Figure 11: Global In Vitro Fertilization Test Market Value (US$ Mn), by Noninvasive Prenatal Testing, 2017-2031
Figure 12: Global In Vitro Fertilization Test Market Value (US$ Mn), by Others, 2017-2031
Figure 13: Global In Vitro Fertilization Test Market Value Share Analysis, by End-user, 2020 and 2031
Figure 14: Global In Vitro Fertilization Test Market Attractiveness Analysis, by End-user, 2021-2031
Figure 15: Global In Vitro Fertilization Test Market Value (US$ Mn), by Fertility Clinics, 2017-2031
Figure 16: Global In Vitro Fertilization Test Market Value (US$ Mn), by Hospitals, 2017-2031
Figure 17: Global In Vitro Fertilization Test Market Value (US$ Mn), by Others, 2017-2031
Figure 18: Global In Vitro Fertilization Test Market Value Share Analysis, by Region, 2020 and 2031
Figure 19: Global In Vitro Fertilization Test Market Attractiveness Analysis, by Region, 2021-2031
Figure 20: North America In Vitro Fertilization Test Market Value (US$ Mn) Forecast, 2017-2031
Figure 21: North America In Vitro Fertilization Test Market Value Share Analysis, by Country, 2020 and 2031
Figure 22: North America In Vitro Fertilization Test Market Attractiveness Analysis, by Country, 2021-2031
Figure 23: North America In Vitro Fertilization Test Market Value Share Analysis, by Test Type, 2020 and 2031
Figure 24: North America In Vitro Fertilization Test Market Attractiveness Analysis, by Test Type, 2021-2031
Figure 25: North America In Vitro Fertilization Test Market Value Share Analysis, by End-user, 2020 and 2031
Figure 26: North America In Vitro Fertilization Test Market Attractiveness Analysis, by End-user, 2021-2031
Figure 27: Europe In Vitro Fertilization Test Market Value (US$ Mn) Forecast, 2017-2031
Figure 28: Europe In Vitro Fertilization Test Market Value Share Analysis, by Country/Sub-region, 2020 and 2031
Figure 29: Europe In Vitro Fertilization Test Market Attractiveness Analysis, by Country/Sub-region, 2021-2031
Figure 30: Europe In Vitro Fertilization Test Market Value Share Analysis, by Test Type, 2020 and 2031
Figure 31: Europe In Vitro Fertilization Test Market Attractiveness Analysis, by Test Type, 2021-2031
Figure 32: Europe In Vitro Fertilization Test Market Value Share Analysis, by End-user, 2020 and 2031
Figure 33: Europe In Vitro Fertilization Test Market Attractiveness Analysis, by End-user, 2021-2031
Figure 34: Asia Pacific In Vitro Fertilization Test Market Value (US$ Mn) Forecast, 2017-2031
Figure 35: Asia Pacific In Vitro Fertilization Test Market Value Share Analysis, by Country/Sub-region, 2020 and 2031
Figure 36: Asia Pacific In Vitro Fertilization Test Market Attractiveness Analysis, by Country/Sub-region, 2021-2031
Figure 37: Asia Pacific In Vitro Fertilization Test Market Value Share Analysis, by Test Type, 2020 and 2031
Figure 38: Asia Pacific In Vitro Fertilization Test Market Attractiveness Analysis, by Test Type, 2021-2031
Figure 39: Asia Pacific In Vitro Fertilization Test Market Value Share Analysis, by End-user, 2020 and 2031
Figure 40: Asia Pacific In Vitro Fertilization Test Market Attractiveness Analysis, by End-user, 2021-2031
Figure 41: Latin America In Vitro Fertilization Test Market Value (US$ Mn) Forecast, 2017-2031
Figure 42: Latin America In Vitro Fertilization Test Market Value Share Analysis, by Country/Sub-region, 2020 and 2031
Figure 43: Latin America In Vitro Fertilization Test Market Attractiveness Analysis, by Country/Sub-region, 2021-2031
Figure 44: Latin America In Vitro Fertilization Test Market Value Share Analysis, by Test Type, 2020 and 2031
Figure 45: Latin America In Vitro Fertilization Test Market Attractiveness Analysis, by Test Type, 2021-2031
Figure 46: Latin America In Vitro Fertilization Test Market Value Share Analysis, by End-user, 2020 and 2031
Figure 47: Latin America In Vitro Fertilization Test Market Attractiveness Analysis, by End-user, 2021-2031
Figure 48: Middle East & Africa In Vitro Fertilization Test Market Value (US$ Mn) Forecast, 2017-2031
Figure 49: Middle East & Africa In Vitro Fertilization Test Market Value Share Analysis, by Country/Sub-region, 2020 and 2031
Figure 50: Middle East & Africa In Vitro Fertilization Test Market Attractiveness Analysis, by Country/Sub-region, 2021-2031
Figure 51: Middle East & Africa In Vitro Fertilization Test Market Value Share Analysis, by Test Type, 2020 and 2031
Figure 52: Middle East & Africa In Vitro Fertilization Test Market Attractiveness Analysis, by Test Type, 2021-2031
Figure 53: Middle East & Africa In Vitro Fertilization Test Market Value Share Analysis, by End-user, 2020 and 2031
Figure 54: Middle East & Africa In Vitro Fertilization Test Market Attractiveness Analysis, by End-user, 2021-2031
Figure 55: Global In Vitro Fertilization Test Market: Company Share Analysis, 2020
Figure 56: CooperSurgical, Inc. Revenue (US$ Mn) and Y-o-Y Growth (%), 2017-2020
Figure 57: CooperSurgical, Inc. Breakdown of Net Sales (%), by Region/Country, 2020
Figure 58: CooperSurgical, Inc. Breakdown of Net Sales (%), by Business Segment, 2020
Figure 59: CooperSurgical, Inc. R&D Expenses (US$ Mn) Y-o-Y Growth (%), 2017-2020
Figure 60: FUJIFILM Holding Corporation Revenue (US$ Mn) and Y-o-Y Growth (%), 2018-2020
Figure 61: FUJIFILM Holding Corporation Revenue Breakdown of Net Sales (%), by Business Segment, 2020
Figure 62: FUJIFILM Holding Corporation R&D Expenses (US$ Mn) and Y-o-Y Growth (%), 2017-2020
Figure 63: Hamilton Thorne, Inc. Revenue (US$ Mn) and Y-o-Y Growth (%), 2018-2020
Figure 64: Hamilton Thorne, Inc. Breakdown of Net Sales (%), by Business Segment, 2020
Figure 65: Hamilton Thorne, Inc. R&D Expenses (US$ Mn) and Y-o-Y Growth (%), 2018-2020
Figure 66: Vitrolife AB Revenue (US$ Mn) and Y-o-Y Growth (%), 2017-2020
Figure 67: Vitrolife AB Breakdown of Net Sales (%), by Region/Country, 2020
Figure 68: Vitrolife AB Breakdown of Net Sales (%), by Business Segment, 2020
Figure 69: Thermo Fisher Scientific Revenue (US$ Mn) and Y-o-Y Growth (%), 2017-2020
Figure 70: Thermo Fisher Scientific Breakdown of Net Sales (%), by Region/Country, 2020
Figure 71: Thermo Fisher Scientific Breakdown of Net Sales (%), by Business Segment, 2020
Figure 72: Thermo Fisher Scientific R&D Expenses (US$ Mn) and Y-o-Y Growth (%), 2017-2020
Figure 73: PerkinElmer, Inc. Revenue (US$ Mn) and Y-o-Y Growth (%), 2017-2020
Figure 74: PerkinElmer, Inc. Breakdown of Net Sales (%), by Region/Country, 2020
Figure 75: PerkinElmer, Inc. Breakdown of Net Sales (%), by Business Segment, 2020
Figure 76: PerkinElmer, Inc. R&D Expenses (US$ Mn) and Y-o-Y Growth (%), 2018-2020
Figure 77: Natera Revenue (US$ Mn) and Y-o-Y Growth (%), 2017-2020
Figure 78: Natera Breakdown of Net Sales (%), by Region/Country, 2020
Figure 79: Natera R&D Expenses (US$ Mn) and Y-o-Y Growth (%), 2018-2020
Figure 80: Takara Bio, Inc. Revenue (US$ Mn) and Y-o-Y Growth (%), 2017-2020
Figure 81: Takara Bio, Inc. Breakdown of Net Sales (%), by Region/Country, 2020
Figure 82: Takara Bio, Inc. Breakdown of Net Sales (%), by Business Segment, 2020
Figure 83: Takara Bio, Inc. R&D Expenses (US$ Mn) and Y-o-Y Growth (%), 2018-2020
1.1. Market Definition and Scope
1.2. Market Segmentation
1.3. Key Research Objectives
1.4. Research Highlights
2. Assumptions and Research Methodology
3. Executive Summary: Global In Vitro Fertilization Test Market
4. Market Overview
4.1. Introduction
4.1.1. Market Introduction
4.1.2. Industry Evolution / Developments
4.2. Overview
4.3. Market Dynamics
4.3.1. Drivers
4.3.2. Restraints
4.3.3. Opportunities
4.4. Global In Vitro Fertilization Test Market Analysis and Forecast, 2017-2031
4.4.1. Market Revenue Projections (US$ Mn)
5. Key Insights
5.1. Key Mergers & Acquisitions
5.2. COVID-19 Pandemics Impact on Industry (Value Chain and Short / Mid /Long Term Impact)
5.3. Regulatory Scenario by Region/globally
5.4. Top 3 players operating in the market space
5.5. Key product/brand Analysis
6. Global In Vitro Fertilization Test Market Analysis and Forecast, by Test Type
6.1. Introduction & Definition
6.2. Key Findings / Developments
6.3. Market Value Forecast, by Test Type, 2017-2031
6.3.1. Sperm Aneuploidy Test
6.3.2. Genetic Compatibility Test
6.3.3. Preimplantation Genetic Testing
6.3.4. Endometrial Receptivity Analysis
6.3.5. Noninvasive Prenatal Testing
6.3.6. Others
6.4. Market Attractiveness Analysis, by Test Type
7. Global In Vitro Fertilization Test Market Analysis and Forecast, by End-user
7.1. Introduction & Definition
7.2. Key Findings / Developments
7.3. Market Value Forecast, by End-user, 2017-2031
7.3.1. Fertility Clinics
7.3.2. Hospitals
7.3.3. Others
7.4. Market Attractiveness Analysis, by End-user
8. Global In Vitro Fertilization Test Market Analysis and Forecast, by Region
8.1. Key Findings
8.2. Market Value Forecast by Region
8.2.1. North America
8.2.2. Europe
8.2.3. Asia Pacific
8.2.4. Latin America
8.2.5. Middle East & Africa
8.3. Market Attractiveness Analysis, by Country/Region
9. North America In Vitro Fertilization Test Market Analysis and Forecast
9.1. Introduction
9.1.1. Key Findings
9.2. Market Value Forecast, by Test Type, 2017-2031
9.2.1. Sperm Aneuploidy Test
9.2.2. Genetic Compatibility Test
9.2.3. Preimplantation Genetic Testing
9.2.4. Endometrial Receptivity Analysis
9.2.5. Noninvasive Prenatal Testing
9.2.6. Others
9.3. Market Value Forecast, by End-user, 2017-2031
9.3.1. Fertility Clinics
9.3.2. Hospitals
9.3.3. Others
9.4. Market Value Forecast, by Country, 2017-2031
9.4.1. U.S.
9.4.2. Canada
9.5. Market Attractiveness Analysis
9.5.1. By Test Type
9.5.2. By End-user
9.5.3. By Country
10. Europe In Vitro Fertilization Test Market Analysis and Forecast
10.1. Introduction
10.1.1. Key Findings
10.2. Market Value Forecast, by Test Type, 2017-2031
10.2.1. Sperm Aneuploidy Test
10.2.2. Genetic Compatibility Test
10.2.3. Preimplantation Genetic Testing
10.2.4. Endometrial Receptivity Analysis
10.2.5. Noninvasive Prenatal Testing
10.2.6. Others
10.3. Market Value Forecast, by End-user, 2017-2031
10.3.1. Fertility Clinics
10.3.2. Hospitals
10.3.3. Others
10.4. Market Value Forecast, by Country/Sub-region, 2017-2031
10.4.1. Germany
10.4.2. U.K.
10.4.3. France
10.4.4. Spain
10.4.5. Italy
10.4.6. Rest of Europe
10.5. Market Attractiveness Analysis
10.5.1. By Test Type
10.5.2. By End-user
10.5.3. By Country/Sub-region
11. Asia Pacific In Vitro Fertilization Test Market Analysis and Forecast
11.1. Introduction
11.1.1. Key Findings
11.2. Market Value Forecast, by Test Type, 2017-2031
11.2.1. Sperm Aneuploidy Test
11.2.2. Genetic Compatibility Test
11.2.3. Preimplantation Genetic Testing
11.2.4. Endometrial Receptivity Analysis
11.2.5. Noninvasive Prenatal Testing
11.2.6. Others
11.3. Market Value Forecast, by End-user, 2017-2031
11.3.1. Fertility Clinics
11.3.2. Hospitals
11.3.3. Others
11.4. Market Value Forecast, by Country/Sub-region, 2017-2031
11.4.1. China
11.4.2. Japan
11.4.3. India
11.4.4. Australia & New Zealand
11.4.5. Rest of Asia Pacific
11.5. Market Attractiveness Analysis
11.5.1. By Test Type
11.5.2. By End-user
11.5.3. By Country/Sub-region
12. Latin America In Vitro Fertilization Test Market Analysis and Forecast
12.1. Introduction
12.1.1. Key Findings
12.2. Market Value Forecast, by Test Type, 2017-2031
12.2.1. Sperm Aneuploidy Test
12.2.2. Genetic Compatibility Test
12.2.3. Preimplantation Genetic Testing
12.2.4. Endometrial Receptivity Analysis
12.2.5. Noninvasive Prenatal Testing
12.2.6. Others
12.3. Market Value Forecast, by End-user, 2017-2031
12.3.1. Fertility Clinics
12.3.2. Hospitals
12.3.3. Others
12.4. Market Value Forecast, by Country/Sub-region, 2017-2031
12.4.1. Brazil
12.4.2. Mexico
12.4.3. Rest of Latin America
12.5. Market Attractiveness Analysis
12.5.1. By Test Type
12.5.2. By End-user
12.5.3. By Country/Sub-region
13. Middle East & Africa In Vitro Fertilization Test Market Analysis and Forecast
13.1. Introduction
13.1.1. Key Findings
13.2. Market Value Forecast, by Test Type, 2017-2031
13.2.1. Sperm Aneuploidy Test
13.2.2. Genetic Compatibility Test
13.2.3. Preimplantation Genetic Testing
13.2.4. Endometrial Receptivity Analysis
13.2.5. Noninvasive Prenatal Testing
13.2.6. Others
13.3. Market Value Forecast, by End-user, 2017-2031
13.3.1. Fertility Clinics
13.3.2. Hospitals
13.3.3. Others
13.4. Market Value Forecast, by Country/Sub-region, 2017-2031
13.4.1. GCC Countries
13.4.2. South Africa
13.4.3. Rest of Middle East & Africa
13.5. Market Attractiveness Analysis
13.5.1. By Test Type
13.5.2. By End-user
13.5.3. By Country/Sub-region
14. Competition Landscape
14.1. Market Player - Competition Matrix (by Tier and Size of companies)
14.2. Market Share Analysis, by Company, 2020
14.3. Company Profiles
14.3.1. CooperSurgical, Inc.
14.3.1.1. Company Overview (HQ, Business Segments, Employee Strength)
14.3.1.2. Growth Strategies
14.3.1.3. SWOT Analysis
14.3.2. Esco Micro Pte Ltd.
14.3.2.1. Company Overview (HQ, Business Segments, Employee Strength)
14.3.2.2. Growth Strategies
14.3.2.3. SWOT Analysis
14.3.3. FUJIFILM Irvine Scientific
14.3.3.1. Company Overview (HQ, Business Segments, Employee Strength)
14.3.3.2. Growth Strategies
14.3.3.3. SWOT Analysis
14.3.4. Hamilton Thorne, Inc.
14.3.4.1. Company Overview (HQ, Business Segments, Employee Strength)
14.3.4.2. Growth Strategies
14.3.4.3. SWOT Analysis
14.3.5. Vitrolife AB
14.3.5.1. Company Overview (HQ, Business Segments, Employee Strength)
14.3.5.2. Growth Strategies
14.3.5.3. SWOT Analysis
14.3.6. IVFtech ApS
14.3.6.1. Company Overview (HQ, Business Segments, Employee Strength)
14.3.6.2. Growth Strategies
14.3.6.3. SWOT Analysis
14.3.7. Nidacon International AB
14.3.7.1. Company Overview (HQ, Business Segments, Employee Strength)
14.3.7.2. Growth Strategies
14.3.7.3. SWOT Analysis
14.3.8. Igenomix
14.3.8.1. Company Overview (HQ, Business Segments, Employee Strength)
14.3.8.2. Growth Strategies
14.3.8.3. SWOT Analysis
14.3.9. Thermo Fisher Scientific
14.3.9.1. Company Overview (HQ, Business Segments, Employee Strength)
14.3.9.2. Growth Strategies
14.3.9.3. SWOT Analysis
14.3.10. Cook
14.3.10.1. Company Overview (HQ, Business Segments, Employee Strength)
14.3.10.2. Growth Strategies
14.3.10.3. SWOT Analysis
14.3.11. Genea Biomedx
14.3.11.1. Company Overview (HQ, Business Segments, Employee Strength)
14.3.11.2. Growth Strategies
14.3.11.3. SWOT Analysis
14.3.12. FertiPro N.V
14.3.12.1. Company Overview (HQ, Business Segments, Employee Strength)
14.3.12.2. Growth Strategies
14.3.12.3. SWOT Analysis
14.3.13. Kitazato Corporation
14.3.13.1. Company Overview (HQ, Business Segments, Employee Strength)
14.3.13.2. Growth Strategies
14.3.13.3. SWOT Analysis
14.3.14. PerkinElmer, Inc.
14.3.14.1. Company Overview (HQ, Business Segments, Employee Strength)
14.3.14.2. Growth Strategies
14.3.14.3. SWOT Analysis
14.3.15. Natera
14.3.15.1. Company Overview (HQ, Business Segments, Employee Strength)
14.3.15.2. Growth Strategies
14.3.15.3. SWOT Analysis
14.3.16. Takara Bio, Inc.
14.3.16.1. Company Overview (HQ, Business Segments, Employee Strength)
14.3.16.2. Growth Strategies
14.3.16.3. SWOT Analysis
14.3.17. iGLS
14.3.17.1. Company Overview (HQ, Business Segments, Employee Strength)
14.3.17.2. Growth Strategies
14.3.17.3. SWOT Analysis
14.3.18. CiceroDx
14.3.18.1. Company Overview (HQ, Business Segments, Employee Strength)
14.3.18.2. Growth Strategies
14.3.18.3. SWOT Analysis
List of Tables
Table 01: Global In Vitro Fertilization Test Market Value (US$ Mn) Forecast, by Test Type, 2017-2031
Table 02: Global In Vitro Fertilization Test Market Value (US$ Mn) Forecast, by End-user, 2017-2031
Table 03: Global In Vitro Fertilization Test Market Value (US$ Mn) Forecast, by Region, 2017-2031
Table 04: North America In Vitro Fertilization Test Market Value (US$ Mn) Forecast, by Country, 2017-2031
Table 05: North America In Vitro Fertilization Test Market Value (US$ Mn) Forecast, by Test Type, 2017-2031
Table 06: North America In Vitro Fertilization Test Market Value (US$ Mn) Forecast, by End-user, 2017-2031
Table 07: Europe In Vitro Fertilization Test Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017-2031
Table 08: Europe In Vitro Fertilization Test Market Value (US$ Mn) Forecast, by Test Type, 2017-2031
Table 09: Europe In Vitro Fertilization Test Market Value (US$ Mn) Forecast, by End-user, 2017-2031
Table 10: Asia Pacific In Vitro Fertilization Test Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017-2031
Table 11: Asia Pacific In Vitro Fertilization Test Market Value (US$ Mn) Forecast, by Test Type, 2017-2031
Table 12: Asia Pacific In Vitro Fertilization Test Market Value (US$ Mn) Forecast, by End-user, 2017-2031
Table 13: Latin America In Vitro Fertilization Test Market Value (US$ Mn) Forecast, by Country/Sub-Region, 2017-2031
Table 14: Latin America In Vitro Fertilization Test Market Value (US$ Mn) Forecast, by Test Type, 2017-2031
Table 15: Latin America In Vitro Fertilization Test Market Value (US$ Mn) Forecast, by End-user, 2017-2031
Table 16: Middle East & Africa In Vitro Fertilization Test Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017-2031
Table 17: Middle East & Africa In Vitro Fertilization Test Market Value (US$ Mn) Forecast, by Test Type, 2017-2031
Table 18: Middle East & Africa In Vitro Fertilization Test Market Value (US$ Mn) Forecast, by End-user, 2017-2031
List of Figures
Figure 01: Global In-vitro Fertilization Test Market Value (US$ Mn) Forecast, 2017-2031
Figure 02: Global In-vitro Fertilization Test Market Value Share, by Test Type, 2020
Figure 03: Global In-vitro Fertilization Test Market Value Share, by End-user, 2020
Figure 04: Global In-vitro Fertilization Test Market Value Share, by Region, 2020
Figure 05: Global In Vitro Fertilization Test Market Value Share Analysis, by Test Type, 2020 and 2031
Figure 06: Global In Vitro Fertilization Test Market Attractiveness Analysis, by Test Type, 2021-2031
Figure 07: Global In Vitro Fertilization Test Market Value (US$ Mn), by Sperm Aneuploidy Test, 2017-2031
Figure 08: Global In Vitro Fertilization Test Market Value (US$ Mn), by Genetic Compatibility Test, 2017-2031
Figure 09: Global In Vitro Fertilization Test Market Value (US$ Mn), by Preimplantation Genetic Testing, 2017-2031
Figure 10: Global In Vitro Fertilization Test Market Value (US$ Mn), by Endometrial Receptivity Analysis, 2017-2031
Figure 11: Global In Vitro Fertilization Test Market Value (US$ Mn), by Noninvasive Prenatal Testing, 2017-2031
Figure 12: Global In Vitro Fertilization Test Market Value (US$ Mn), by Others, 2017-2031
Figure 13: Global In Vitro Fertilization Test Market Value Share Analysis, by End-user, 2020 and 2031
Figure 14: Global In Vitro Fertilization Test Market Attractiveness Analysis, by End-user, 2021-2031
Figure 15: Global In Vitro Fertilization Test Market Value (US$ Mn), by Fertility Clinics, 2017-2031
Figure 16: Global In Vitro Fertilization Test Market Value (US$ Mn), by Hospitals, 2017-2031
Figure 17: Global In Vitro Fertilization Test Market Value (US$ Mn), by Others, 2017-2031
Figure 18: Global In Vitro Fertilization Test Market Value Share Analysis, by Region, 2020 and 2031
Figure 19: Global In Vitro Fertilization Test Market Attractiveness Analysis, by Region, 2021-2031
Figure 20: North America In Vitro Fertilization Test Market Value (US$ Mn) Forecast, 2017-2031
Figure 21: North America In Vitro Fertilization Test Market Value Share Analysis, by Country, 2020 and 2031
Figure 22: North America In Vitro Fertilization Test Market Attractiveness Analysis, by Country, 2021-2031
Figure 23: North America In Vitro Fertilization Test Market Value Share Analysis, by Test Type, 2020 and 2031
Figure 24: North America In Vitro Fertilization Test Market Attractiveness Analysis, by Test Type, 2021-2031
Figure 25: North America In Vitro Fertilization Test Market Value Share Analysis, by End-user, 2020 and 2031
Figure 26: North America In Vitro Fertilization Test Market Attractiveness Analysis, by End-user, 2021-2031
Figure 27: Europe In Vitro Fertilization Test Market Value (US$ Mn) Forecast, 2017-2031
Figure 28: Europe In Vitro Fertilization Test Market Value Share Analysis, by Country/Sub-region, 2020 and 2031
Figure 29: Europe In Vitro Fertilization Test Market Attractiveness Analysis, by Country/Sub-region, 2021-2031
Figure 30: Europe In Vitro Fertilization Test Market Value Share Analysis, by Test Type, 2020 and 2031
Figure 31: Europe In Vitro Fertilization Test Market Attractiveness Analysis, by Test Type, 2021-2031
Figure 32: Europe In Vitro Fertilization Test Market Value Share Analysis, by End-user, 2020 and 2031
Figure 33: Europe In Vitro Fertilization Test Market Attractiveness Analysis, by End-user, 2021-2031
Figure 34: Asia Pacific In Vitro Fertilization Test Market Value (US$ Mn) Forecast, 2017-2031
Figure 35: Asia Pacific In Vitro Fertilization Test Market Value Share Analysis, by Country/Sub-region, 2020 and 2031
Figure 36: Asia Pacific In Vitro Fertilization Test Market Attractiveness Analysis, by Country/Sub-region, 2021-2031
Figure 37: Asia Pacific In Vitro Fertilization Test Market Value Share Analysis, by Test Type, 2020 and 2031
Figure 38: Asia Pacific In Vitro Fertilization Test Market Attractiveness Analysis, by Test Type, 2021-2031
Figure 39: Asia Pacific In Vitro Fertilization Test Market Value Share Analysis, by End-user, 2020 and 2031
Figure 40: Asia Pacific In Vitro Fertilization Test Market Attractiveness Analysis, by End-user, 2021-2031
Figure 41: Latin America In Vitro Fertilization Test Market Value (US$ Mn) Forecast, 2017-2031
Figure 42: Latin America In Vitro Fertilization Test Market Value Share Analysis, by Country/Sub-region, 2020 and 2031
Figure 43: Latin America In Vitro Fertilization Test Market Attractiveness Analysis, by Country/Sub-region, 2021-2031
Figure 44: Latin America In Vitro Fertilization Test Market Value Share Analysis, by Test Type, 2020 and 2031
Figure 45: Latin America In Vitro Fertilization Test Market Attractiveness Analysis, by Test Type, 2021-2031
Figure 46: Latin America In Vitro Fertilization Test Market Value Share Analysis, by End-user, 2020 and 2031
Figure 47: Latin America In Vitro Fertilization Test Market Attractiveness Analysis, by End-user, 2021-2031
Figure 48: Middle East & Africa In Vitro Fertilization Test Market Value (US$ Mn) Forecast, 2017-2031
Figure 49: Middle East & Africa In Vitro Fertilization Test Market Value Share Analysis, by Country/Sub-region, 2020 and 2031
Figure 50: Middle East & Africa In Vitro Fertilization Test Market Attractiveness Analysis, by Country/Sub-region, 2021-2031
Figure 51: Middle East & Africa In Vitro Fertilization Test Market Value Share Analysis, by Test Type, 2020 and 2031
Figure 52: Middle East & Africa In Vitro Fertilization Test Market Attractiveness Analysis, by Test Type, 2021-2031
Figure 53: Middle East & Africa In Vitro Fertilization Test Market Value Share Analysis, by End-user, 2020 and 2031
Figure 54: Middle East & Africa In Vitro Fertilization Test Market Attractiveness Analysis, by End-user, 2021-2031
Figure 55: Global In Vitro Fertilization Test Market: Company Share Analysis, 2020
Figure 56: CooperSurgical, Inc. Revenue (US$ Mn) and Y-o-Y Growth (%), 2017-2020
Figure 57: CooperSurgical, Inc. Breakdown of Net Sales (%), by Region/Country, 2020
Figure 58: CooperSurgical, Inc. Breakdown of Net Sales (%), by Business Segment, 2020
Figure 59: CooperSurgical, Inc. R&D Expenses (US$ Mn) Y-o-Y Growth (%), 2017-2020
Figure 60: FUJIFILM Holding Corporation Revenue (US$ Mn) and Y-o-Y Growth (%), 2018-2020
Figure 61: FUJIFILM Holding Corporation Revenue Breakdown of Net Sales (%), by Business Segment, 2020
Figure 62: FUJIFILM Holding Corporation R&D Expenses (US$ Mn) and Y-o-Y Growth (%), 2017-2020
Figure 63: Hamilton Thorne, Inc. Revenue (US$ Mn) and Y-o-Y Growth (%), 2018-2020
Figure 64: Hamilton Thorne, Inc. Breakdown of Net Sales (%), by Business Segment, 2020
Figure 65: Hamilton Thorne, Inc. R&D Expenses (US$ Mn) and Y-o-Y Growth (%), 2018-2020
Figure 66: Vitrolife AB Revenue (US$ Mn) and Y-o-Y Growth (%), 2017-2020
Figure 67: Vitrolife AB Breakdown of Net Sales (%), by Region/Country, 2020
Figure 68: Vitrolife AB Breakdown of Net Sales (%), by Business Segment, 2020
Figure 69: Thermo Fisher Scientific Revenue (US$ Mn) and Y-o-Y Growth (%), 2017-2020
Figure 70: Thermo Fisher Scientific Breakdown of Net Sales (%), by Region/Country, 2020
Figure 71: Thermo Fisher Scientific Breakdown of Net Sales (%), by Business Segment, 2020
Figure 72: Thermo Fisher Scientific R&D Expenses (US$ Mn) and Y-o-Y Growth (%), 2017-2020
Figure 73: PerkinElmer, Inc. Revenue (US$ Mn) and Y-o-Y Growth (%), 2017-2020
Figure 74: PerkinElmer, Inc. Breakdown of Net Sales (%), by Region/Country, 2020
Figure 75: PerkinElmer, Inc. Breakdown of Net Sales (%), by Business Segment, 2020
Figure 76: PerkinElmer, Inc. R&D Expenses (US$ Mn) and Y-o-Y Growth (%), 2018-2020
Figure 77: Natera Revenue (US$ Mn) and Y-o-Y Growth (%), 2017-2020
Figure 78: Natera Breakdown of Net Sales (%), by Region/Country, 2020
Figure 79: Natera R&D Expenses (US$ Mn) and Y-o-Y Growth (%), 2018-2020
Figure 80: Takara Bio, Inc. Revenue (US$ Mn) and Y-o-Y Growth (%), 2017-2020
Figure 81: Takara Bio, Inc. Breakdown of Net Sales (%), by Region/Country, 2020
Figure 82: Takara Bio, Inc. Breakdown of Net Sales (%), by Business Segment, 2020
Figure 83: Takara Bio, Inc. R&D Expenses (US$ Mn) and Y-o-Y Growth (%), 2018-2020
Note: Product cover images may vary from those shown
- CooperSurgical, Inc.
- Esco Micro Pte Ltd.
- FUJIFILM Irvine Scientific
- Hamilton Thorne, Inc.
- Vitrolife AB
- IVFtech ApS
- Nidacon International AB
- Igenomix
- Thermo Fisher Scientific
- Cook
- Genea Biomedx
- FertiPro N.V
- Kitazato Corporation
- PerkinElmer, Inc.
- Natera
- Takara Bio, Inc.
- iGLS
- CiceroDx
Note: Product cover images may vary from those shown
